Therapeutic targeting of tumour myeloid cells

ST Barry, DI Gabrilovich, OJ Sansom… - Nature Reviews …, 2023 - nature.com
Myeloid cells are pivotal within the immunosuppressive tumour microenvironment. The
accumulation of tumour-modified myeloid cells derived from monocytes or neutrophils …

The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion

P De Cicco, G Ercolano, A Ianaro - Frontiers in immunology, 2020 - frontiersin.org
Suppression of antitumor immune responses is one of the main mechanisms by which tumor
cells escape from destruction by the immune system. Myeloid-derived suppressor cells …

Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3

HI Scher, MJ Morris, WM Stadler, C Higano… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Evolving treatments, disease phenotypes, and biology, together with a changing
drug development environment, have created the need to revise castration-resistant prostate …

The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis

RD Dolan, ST McSorley, PG Horgan, B Laird… - Critical reviews in …, 2017 - Elsevier
Introduction Cancer remains a leading cause of death worldwide. While a curative intent is
the aim of any surgical treatment many patients either present with or go onto develop …

Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies

Z Mei, L Shi, B Wang, J Yang, Z Xiao, P Du… - Cancer treatment …, 2017 - Elsevier
Background Neutrophil-to-lymphocyte ratio (NLR) is crucial for the incidence and mortality of
various tumors. However, little is known on NLR and its association with prognosis in …

Regulation of prostate cancer progression by the tumor microenvironment

SL Shiao, GCY Chu, LWK Chung - Cancer letters, 2016 - Elsevier
Prostate cancer remains the most frequently diagnosed cancer in men in North America, and
despite recent advances in treatment patients with metastatic disease continue to have poor …

High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy

EK Bartlett, JR Flynn, KS Panageas, RA Ferraro… - Cancer, 2020 - Wiley Online Library
Background An elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poor
survival in patients with cancer, including those who receive immunotherapies. The authors …

Immune infiltration and prostate cancer

A Strasner, M Karin - Frontiers in oncology, 2015 - frontiersin.org
It is becoming increasingly clear that inflammation influences prostate cancer (PCa)
development and that immune cells are among the primary drivers of this effect. This …

[HTML][HTML] Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate …

D Lorente, J Mateo, AJ Templeton, Z Zafeiriou… - Annals of …, 2015 - Elsevier
We investigated the value of the neutrophil–lymphocyte ratio (NLR) in patients with CRPC
treated with chemotherapy in the phase III TROPIC trial. High NLR was associated with …

The evolving role of immune cells in prostate cancer

C Wang, Y Zhang, WQ Gao - Cancer letters, 2022 - Elsevier
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of
cancer-related death among men in western countries. Androgen deprivation therapy (ADT) …